Profile data is unavailable for this security.
About the company
Hua Medicine is a China-based company principally engaged in the drug development business. The Company is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The Company mainly operates its business in the domestic and overseas markets.
- Revenue in HKD (TTM)120.37m
- Net income in HKD-291.00m
- Incorporated2009
- Employees172.00
- LocationHua MedicineHua Medicine, 275 Ai Di Sheng RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 158869997
- Websitehttps://www.huamedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brii Biosciences Ltd | 0.00 | -293.28m | 745.21m | 95.00 | -- | 0.2357 | -- | -- | -0.4019 | -0.4019 | 0.00 | 4.33 | 0.00 | -- | -- | 0.00 | -8.89 | -- | -9.01 | -- | -- | -- | -- | -- | -- | -- | 0.007 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
Genor Biopharma Holdings Ltd | 15.99m | -580.61m | 857.97m | 28.00 | -- | 0.7229 | -- | 53.67 | -1.14 | -1.14 | 0.0315 | 2.28 | 0.0093 | 0.0178 | 0.2277 | 153,724.00 | -33.87 | -55.46 | -39.06 | -63.73 | 97.59 | 66.56 | -3,638.27 | -14,819.18 | 5.73 | -- | 0.003 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
Sunho Biologics Inc | -100.00bn | -118.54m | 908.67m | -- | -- | 1.50 | -- | -- | -0.88 | -0.88 | -- | 3.86 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.77 | -4,626.67 | 0.0516 | -- | -- | -- | -155.25 | -- | -- | -- |
Wuhan YZY Biopharma Co Ltd | 0.00 | -202.77m | 1.19bn | 114.00 | -- | 21.79 | -- | -- | -1.06 | -1.06 | 0.00 | 0.2826 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -44.35 | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
Frontage Holdings Corp | 2.03bn | 47.51m | 1.20bn | 1.66k | 25.67 | 0.4581 | 3.55 | 0.5931 | 0.023 | 0.023 | 0.9889 | 1.29 | 0.4701 | 56.23 | 4.58 | 1,151,305.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.37 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Hua Medicine | 120.37m | -291.00m | 1.24bn | 172.00 | -- | -- | -- | 10.26 | -0.2968 | -0.2968 | 0.1228 | -0.0374 | 0.0779 | 1.51 | 1.90 | 680,030.60 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Immunotech Biopharm Ltd | 0.00 | -341.64m | 1.25bn | 211.00 | -- | 13.90 | -- | -- | -0.6639 | -0.6639 | 0.00 | 0.1741 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.44 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Mabpharm Ltd | 167.52m | -228.62m | 1.26bn | 347.00 | -- | 9.88 | -- | 7.51 | -0.0554 | -0.0554 | 0.0406 | 0.0309 | 0.164 | 0.1937 | 3.26 | 482,775.10 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -23.09 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Jacobio Pharmaceuticals Group Co Ltd | 25.62m | -399.84m | 1.35bn | 298.00 | -- | 1.35 | -- | 52.70 | -0.5151 | -0.5151 | 0.033 | 1.27 | 0.016 | -- | 2.41 | 85,103.41 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
TOT Biopharm International Co Ltd | 1.08bn | 9.91m | 1.55bn | 551.00 | 146.46 | 1.93 | 22.03 | 1.44 | 0.0137 | 0.0137 | 1.48 | 1.03 | 0.6899 | 2.44 | 6.35 | 1,951,385.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
CARsgen Therapeutics Holdings Ltd | 7.00m | -767.74m | 1.70bn | 477.00 | -- | 1.03 | -- | 242.33 | -1.38 | -1.38 | 0.0126 | 2.87 | 0.0027 | -- | 0.302 | 13,575.19 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
Laekna Inc | 0.00 | -326.52m | 1.74bn | 92.00 | -- | 2.33 | -- | -- | -0.9163 | -0.9163 | 0.00 | 1.92 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 1.84bn | 145.00 | -- | 2.78 | -- | -- | -- | -- | -- | 1.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Data as of Sep 24 2024. Currency figures normalised to Hua Medicine's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Baillie Gifford & Co.as of 31 Jul 2024 | 23.86m | 2.26% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 14.26m | 1.35% |
Allspring Global Investments LLCas of 30 Jun 2024 | 10.58m | 1.00% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 5.88m | 0.56% |
CRUX Asset Management Ltd.as of 31 Mar 2023 | 4.07m | 0.39% |
State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 2.32m | 0.22% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 560.00k | 0.05% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 180.00k | 0.02% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 155.40k | 0.02% |
Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.